Hospital Corporation of China Dirección

Dirección controles de criterios 2/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Shuai Chen

Chief Executive Officer (CEO)

n/a

Compensación total

Porcentaje del salario del CEO	n/a
Permanencia del CEO	4.4yrs
Participación del CEO	n/a
Permanencia media de la dirección	3.7yrs
Promedio de permanencia en la Junta Directiva	6.1yrs

Actualizaciones recientes de la dirección

Recent updates

We Think Hospital Corporation of China (HKG:3869) Can Stay On Top Of Its Debt

Oct 01

Not Many Are Piling Into Hospital Corporation of China Limited (HKG:3869) Stock Yet As It Plummets 28%

Aug 30

We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve

Apr 29

Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company

Jun 30

Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns

May 17

Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?

Apr 12

Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?

Mar 08

Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?

Jan 14

Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt

Dec 10

CEO

Shuai Chen (50 yo)

4.4yrs

Permanencia

Mr. Shuai Chen has been an Acting Chief Executive Officer at Hospital Corporation of China Limited since June 23, 2020 and its Executive Director since November 20, 2020. He served as Director at I-Mab sin...

Equipo directivo

Nombre	Posición	Permanencia	Compensación	Propiedad
Shuai Chen	Executive Chairman & Acting CEO	4.4yrs	sin datos	sin datos
Jianli Pan	Executive Director & CFO	3.6yrs	CN¥1.81m	sin datos
Chengchuan Pu	Executive Director	3.4yrs	sin datos	sin datos
Hui Liu	Assistant President	no data	sin datos	sin datos
Yuanzhi Wu	Executive Vice President	1.8yrs	sin datos	sin datos
Xiaofeng Lang	Chief Company Development Officer & Assistant to the Chairman	4.2yrs	sin datos	sin datos
Wing Yan Ho	Company Secretary	3.8yrs	sin datos	sin datos

3.7yrs

Permanencia media

43yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 3869 se considera experimentado (3.7 años antigüedad media).

Miembros de la Junta

Nombre	Posición	Permanencia	Compensación	Propiedad
Shuai Chen	Executive Chairman & Acting CEO	4.4yrs	sin datos	sin datos
Jianli Pan	Executive Director & CFO	2.7yrs	CN¥1.81m	sin datos
Chengchuan Pu	Executive Director	3.4yrs	sin datos	sin datos
Nan Wang	Non-Executive Director	7.5yrs	sin datos	sin datos
Luwen Shi	Independent Non-Executive Director	7.9yrs	CN¥150.00k	sin datos
Xiangliang Zhou	Independent Non-Executive Director	7.9yrs	CN¥150.00k	sin datos
Lu Liu	Non-Executive Director	7.5yrs	sin datos	sin datos
Jinxue Dang	Independent Non-Executive Director	4.7yrs	CN¥150.00k	sin datos

6.1yrs

Permanencia media

49yo

Promedio de edad

Junta con experiencia: La junta directiva de 3869 se considera experimentada (6.1 años de antigüedad promedio).

Hospital Corporation of China Dirección

Dirección controles de criterios 2/4

Información clave

Actualizaciones recientes de la dirección

Hospital Corporation of China Limited, Annual General Meeting, Jun 20, 2024

Hospital Corporation of China Limited Announces Resignation of Lu Wenzuo as Executive Director

Less than half of directors are independent

Hospital Corporation of China Limited, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Hospital Corporation of China Limited Announces Executive Changes

Recent updates

We Think Hospital Corporation of China (HKG:3869) Can Stay On Top Of Its Debt

First half 2024 earnings released: CN¥0.14 loss per share (vs CN¥0.91 profit in 1H 2023)

Not Many Are Piling Into Hospital Corporation of China Limited (HKG:3869) Stock Yet As It Plummets 28%

Hospital Corporation of China Limited to Report First Half, 2024 Results on Aug 29, 2024

New minor risk - Market cap size

We Think Hospital Corporation of China's (HKG:3869) Profit Is Only A Baseline For What They Can Achieve

Hospital Corporation of China Limited, Annual General Meeting, Jun 20, 2024

New major risk - Financial position

Full year 2023 earnings released: EPS: CN¥0.96 (vs CN¥3.48 loss in FY 2022)

Hospital Corporation of China Limited to Report Fiscal Year 2023 Results on Mar 26, 2024

Investor sentiment deteriorates as stock falls 22%

New minor risk - Share price stability

Investor sentiment improves as stock rises 26%

First half 2023 earnings released: EPS: CN¥0.91 (vs CN¥3.09 loss in 1H 2022)

Investor sentiment improves as stock rises 23%

First half 2023 earnings released: EPS: CN¥0.91 (vs CN¥3.08 loss in 1H 2022)

Hospital Corporation of China Limited to Report Q2, 2023 Results on Aug 30, 2023

New minor risk - Market cap size

Now 36% undervalued after recent price drop

New minor risk - Share price stability

Hospital Corporation of China Limited (HKG:3869) Stock Rockets 33% But Many Are Still Ignoring The Company

Full year 2022 earnings released: CN¥3.48 loss per share (vs CN¥2.03 loss in FY 2021)

Hospital Corporation of China Limited Announces Resignation of Lu Wenzuo as Executive Director

Less than half of directors are independent

First half 2022 earnings released: CN¥3.08 loss per share (vs CN¥2.47 loss in 1H 2021)

First half 2022 earnings released: CN¥3.09 loss per share (vs CN¥2.47 loss in 1H 2021)

Hospital Corporation of China Limited to Report Q2, 2022 Results on Aug 30, 2022

Hospital Corporation of China Limited Provides Unaudited Consolidated Earnings Guidance for the Six Months Ended June 30, 2022

Hospital Corporation of China Limited, Annual General Meeting, Jun 22, 2022

Less than half of directors are independent

Full year 2021 earnings released: CN¥2.03 loss per share (vs CN¥2.93 loss in FY 2020)

Hospital Corporation of China Limited Announces Executive Changes

First half 2021 earnings released: CN¥2.47 loss per share (vs CN¥3.87 loss in 1H 2020)

Non Executive Director Zhiqiang Su has left the company

Hospital Corporation of China (HKG:3869) Hasn't Managed To Accelerate Its Returns

Full year 2020 earnings released: CN¥2.93 loss per share (vs CN¥1.09 profit in FY 2019)

Does Hospital Corporation of China (HKG:3869) Have A Healthy Balance Sheet?

Full year 2020 earnings released: CN¥2.93 loss per share (vs CN¥1.09 profit in FY 2019)

Hospital Corporation of China Limited to Report Fiscal Year 2020 Results on Mar 30, 2021

Would Shareholders Who Purchased Hospital Corporation of China's (HKG:3869) Stock Three Years Be Happy With The Share price Today?

New 90-day high: HK$11.38

Hospital Corporation of China Limited Announces Executive Changes

Should You Be Impressed By Hospital Corporation of China's (HKG:3869) Returns on Capital?

New 90-day low: HK$10.60

New 90-day low: HK$10.90

Hospital Corporation of China (HKG:3869) Takes On Some Risk With Its Use Of Debt

Hospital Corporation of China Limited Announces Management Changes

First half earnings released

Hospital Corporation of China Limited to Report First Half, 2020 Results on Aug 28, 2020

CEO

Permanencia

Equipo directivo

Permanencia media

Promedio de edad

Miembros de la Junta

Permanencia media

Promedio de edad